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ABSTRACT 
Purpose: Egypt has the highest prevalence of chronic Hepatitis C virus (HCV) infections 
and also a high prevalence of female genital mutilation (FGM). The high prevalence 
chronic hepatitis C has been attributed to HCV transmission by contaminated injections 
for the control of schistosomiasis. HCV infection has not been well studied in the context 
of female genital mutilation (FGM). We sought to identify associations between FGM 
and HCV using the Egypt Demographic and Health Survey (EDHS), 2008.  
Methods: FGM was chosen as the main independent variable of interest. Other 
independent variables such as age, education, marital status, residence, beliefs associated 
with FGM, history of blood transfusion, surgery, sharing needles, and history of 
schistosomiasis were included in the analysis. Throughout the analysis, HCV infection 
was used as the main dependent variable. 
 Results: Univariate analysis of FGM and HCV showed a statistically significant 
association with a Prevalence Odds Ratio of 4.82 (2.91 -7.96), after adjusting for age and 
schistosomiasis injection, the association between FGM and HCV remained statistically 
significant with an odds of 2.98 (1.76 – 5.05)Among the category for FGM performer 
and association with HCV infection, the OR was 4.28 (2.31 – 7.91) when the FGM was 
performed by a ghagaria, 3.68 (2.76 - 4.90) when the FGM was performed by daya, and 
3.30 (1.81 -5.88) when the FGM was performed by a barber. Among other independent 
variables, a lack of education, rural residence, and having religious precepts for FGM had 
statistically increased odds of association with HCV infection. 
Conclusion: There is a statistically significant association between FGM and HCV 
infection. There are increased odds of HCV when the FGM is performed by providers 
other than doctors. Participants from a rural residence and who those who did not have 
any education were at increased odds of HCV. Subjects who believed in religious 
precepts for FGM and also who answered that FGM can continue had increased odds of 
association with HCV infections. 
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Chapter I 
Introduction 
1a. Background 
Globally, the World health Organization (WHO) estimates that each year 3-4 
million people are newly infected with Hepatitis C virus (HCV); 150 million live with 
chronic infection and are at risk of developing cirrhosis or liver cancer; and 350,000 
people die due to HCV related illnesses (WHO). Egypt has the highest prevalence of 
Hepatitis C in the world (Lavanchy, 2009).  According to the WHO, the rate of chronic 
infection is 15% in Egypt, 4.8% in Pakistan, and 3.2% in China. The Egyptian Ministry 
of Health Program(MOHP) has two kinds of programs: one largely aimed at treatment of 
current chronic infections, and a second focused on prevention efforts to decrease HCV 
transmission(Yahia, 2011). However, a majority of the resources are allocated to 
treatment of HCV rather than prevention(Yahia, 2011). Yet, diagnosis and treatment lead 
to complete recovery in only 60% of cases and alone do not prevent transmission(Kamili, 
Drobeniuc, Araujo, & Hayden, 2012; Pawlotsky, 2004). Specific treatment for chronic 
HCV in Egypt requires at least a 36 week regimen of interferon and ribavirin  and costs 
about US$ 3500, a price well above the Egyptian median income of US $ 2,070 per 
person per year (Yahia, 2011). Perhaps, diverting some of the funds towards prevention 
will offset the disease transmission, and the societal and economic burden of chronic 
HCV. 
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        Focusing on prevention requires identification of major transmission risk factors and 
taking actions to curtail their impact. HCV transmission occurs through percutaneous 
exposure to infected blood (CDC). Given this fact that HCV can be transmitted through 
infected blood, it is reasonable to explore cultural practices that involve bloodletting, 
such as female genital mutilation, which is widespread in Egypt(El-Gibaly, Ibrahim, 
Mensch, & Clark, 2002). FGM is defined by the WHO as “all procedures that involve 
partial or total removal of the female genitalia, or other injury to the female genital 
organs for non-medical reasons” (WHO).  Immediate complications of the FGM 
procedure include minor to severe bleeding depending on the amount of tissue 
excised(Momoh et al., 2001). FGM is a practice that is widespread in Egypt(El-Gibaly, 
Ibrahim, Mensch, & Clark, 2002). FGM is practiced in the African continent stretching 
from Senegal in the east, Egypt in the northeast and extends as far as Tanzania in the 
south (Kouba & Muasher, 1985). Of the 140 million girls and women who are currently 
living with FGM, 101 million reside in the African continent (WHO). The procedure is 
usually performed by medically unqualified people, who sometimes use unsterile 
instruments such as razor blades, knives, broken glass, sharp stones, or scalpels likely to 
be contaminated with disease agents (Momoh, Ladhani, Lochrie, & Rymer, 2001; Slack, 
1988). Since FGM can be performed using unsterile instruments, and also involves 
bloodletting, we explored the association between FGM and HCV in Egypt.  
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1b. Purpose of the study 
The goal of this study is to add to the evidence of risk factors for HCV 
seropositivity in Egypt, with a particular focus on FGM as a risk factor for hepatitis C.  
Using Demographic Health Survey data from Egypt (EDHS) in 2008, the prevalence 
rates of hepatitis C among women based on demographic, behavioral, and clinical 
variables were examined. The study goals are:  
 To evaluate the association between HCV infection and FGM;  
 To determine possible relationships between HCV infection and the type of 
provider who performs FGM (doctor, lay provider, etc.) 
 To examine possible associations between social-demographic factors and HCV 
infection; 
 To assess the relationship between HCV infection and knowledge and attitudes of 
women regarding FGM;  
 To analyze clinical/iatrogenic risk factors such as, a history of blood transfusion, 
surgery, injection for schistosomiasis, etc., and their relationship with HCV. 
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CHAPTER II 
REVIEW OF LITERATURE 
2a. Virology and pathophysiology 
The term hepatitis refers to inflammation of the liver which can be caused by 
infectious agents, such as viruses, or non-infectious agents, such as alcohol and drugs 
(http://www.cdc.gov/hepatitis/). The five most common types of viral hepatitis are caused 
by hepatitis A, B, C, D and E viruses, after which they are also named 
(http://www.cdc.gov/hepatitis/).  The Hepatitis C virus (HCV) is a member of the genus 
Hepacivirus and the Flaviviridae family(Pawlotsky, 2004). The name HCV refers to any 
of six main groups (clades 1-6) or any of a number of subgroups of enveloped, single-
stranded RNA viruses(Pawlotsky, 2004). Each Hepatitis C virus or HCV contains one 
polyprotein, which is processed in human liver cells or hepatocytes into structural (C, E1, 
E2 and p7) and nonstructural (NS1-3, NS4A-B and NS5A-B) subunits. In addition to this 
diversity in the types of HCV, HCV viruses are also highly mutative, with a mutation rate 
of 10
–3
 per nucleotide per generation(Chisari, 2005) (Chisari, 2005). 
Initial HCV infection is often asymptomatic and self-resolving in 20% to 50% of 
cases by six months following infection(Pawlotsky, 2004). In most cases (50–80%), HCV 
infection becomes chronic(Pawlotsky, 2004). Although much of the mechanism of 
infection remains unknown, chronicity is impacted by weak CD41 and CD81 T-cell 
responses in human cells during the acute infection phase(Pawlotsky, 2004). This weak 
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response to the viral infection in some people could be due in part to the diversity of the 
virus, its high replication rate (10
12
virions per day) and its ability to evolve new means of 
evading host cell defenses quickly after infection due to its high mutation rate (Chisari, 
2005). Indeed, it is unknown whether the inability to clear the virus in the first six months 
in some people is due to antigen overload (resulting from all the factors previously 
listed), changes to the normal viral detection by the host cell caused by the virus, 
individual genetics or other factors(Chisari, 2005).  
Even when chronic infection is established, HCV does not directly kill liver cells, 
except in the case of one specific clade called the HCV3(Pawlotsky, 2004). HCV3 
directly induces lesions or accumulation of lipids in the hepatocytes referred to as 
steatosis(Pawlotsky, 2004). In most cases, steatosis is caused instead by locally driven 
immune responses, which are mainly non-specific and lead to inflammation(Chisari, 
2005).  Constant inflammation leads to death of liver cells and triggers fibrogenesis or the 
excessive buildup of collagen and other extracellular matrix constituents in the liver 
(Pawlotsky, 2004). Cirrhosis or scarring of the liver develops with increasing buildup and 
is facilitated by external factors, such as chronic alcohol consumption and viral co-
infections, for example with HIV(Pawlotsky, 2004). Chronic infection with HCV causes 
cirrhosis in 10–20% of cases after 10–20 years of infection, and hepatocellular carcinoma 
or liver cancer in 1–4% of cases per year, in patients with HCV-related 
cirrhosis(Pawlotsky, 2004). Chronic HCV is also associated with other systemic 
conditions such as renal and skin diseases (Gumber & Chopra, 1995).                   
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2b. Diagnosis and treatment 
 Around the world, approximately 170 million people are infected with the virus. 
When symptomatic, acute infection, or infection in the first six months of acquiring the 
virus, can be characterized by nausea, vomiting, abdominal pain, fatigue, pale colored 
stools and fever (Hoofnagle, 2003). However, only one-third of patients with acute 
infection have clinical manifestations (Gumber & Chopra, 1995). In addition to showing 
no clinical signs during the acute stage, about 50-80% of infected people go on to become 
chronic cases(Pawlotsky, 2004). According to the CDC, of those with chronic HCV, 60-
70% of people show signs of liver disease, while many others who have chronic HCV 
infection do not have apparent clinical signs and are not aware of their infection, which 
allows them to serve as a major reservoir of the virus 
(http://www.cdc.gov/hepatitis/HCV/HCVfaq.htm#a14). The transmission of HCV occurs 
by contact with blood of an infected person(Pawlotsky, 2004).  HCV is highly 
transmissible through repeated percutaneous exposure to infected blood, but any kind of 
parenteral transmission, such as occupational and perinatal exposure, can also lead to the 
transmission of HCV (http://www.cdc.gov/hepatitis/HCV/HCVfaq.htm#a14). 
For infected people, conclusive diagnosis of HCV is somewhat 
problematic(Kamili et al., 2012). A review by Kamili, Drobeniuc, Araujo and Hayden 
(2012) describes the evolution of diagnosis of this virus. According to the review, in most 
laboratories, the first step of diagnosis involves detecting the presence of antibodies, or 
anti-HCV immunoglobulin G/IgG using assay, which is detectable after 8-9 weeks. 
However, the presence of anti-HCV alone cannot distinguish acute from chronic 
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infection, and cannot separate past infection that has already been cleared from current 
infection definitively(Kamili et al., 2012). Per Kamili and colleagues, the gold standard 
for the detection of current infection is the detection of HCV RNA through nucleic acid 
testing (NAT). Due to the requirements for this particular procedure, including expert 
technical staffs, expensive equipment and reagents, appropriate space and pristine serum 
or plasma samples, most laboratories do not actually use this procedure(Kamili et al., 
2012).  
If a person is successfully diagnosed with HCV, their treatment options are pretty 
limited. Currently, interferon and ribavirin for a period of thirty six weeks is used, and 
this is effective in clearing 60% of chronic HCV infections(Kamal et al., 2005). 
Vaccination against HCV is not yet available(Chisari, 2005), and prophylaxis with 
immunoglobulin is not effective after exposure already occurred(McGee, Cupell, 
Higgins, Renshaw, & Shaver, 2001). Since there is no vaccine and no post-exposure 
prophylaxis available, it is imperative to focus on methods to prevent the exposure from 
occurring (Alter, 1997; Control & Prevention, 1998) ( http://www.cdc.gov).                      
2c. Women and HCV  
In Egypt, several factors make women more susceptible to HCV than men, 
including women being more limited in their knowledge of the causes and transmission 
of this condition and the socio-economic disparities between the two genders.  In Egypt’s 
2008 DHS health survey, men and women who were tested for HCV between ages 15-59 
were asked specific questions pertaining to their knowledge and attitudes about hepatitis 
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C (El-Zanaty, Fatma, and Ann Way, 2009).  Specifically, the survey questions included 
those who had heard about HCV, their understanding about the modes of transmission 
and prevention, and the sources from which they had received information. The test 
results indicate that in general, men (85%) were relatively more knowledgeable about 
hepatitis C than women (80%). Specifically, only 40% of female respondents were aware 
that HCV can be transmitted by coming in contact with the blood of an infected 
individual compared to 54% of males. Similar differences were found among men and 
women in questionnaires about transmission of HCV through unclean needles. 
In addition to a gap in knowledge between men and women, there is significant 
evidence of a gender difference in the transmission of HCV. Wives were more likely to 
transmit the virus to their husbands than vice versa (Magder et al., 2005). A cross 
sectional serological survey was conducted to study the transmission of hepatitis C 
among spouses in two communities of Egypt (Magder et al., 2005). In that study, the 
probability of wife to husband transmission was 34% for HCV RNA positive wives and 
10% for HCV RNA negative wives, due to the higher transmissibility of ongoing acute 
infection. Interestingly, the probability of husband to wife transmission was lesser; 3% 
for HCV RNA positive husbands to 0% for HCV RNA negative husbands. This study 
suggests that women are better able to transmit the virus than men, but the reason is 
unknown. 
Similarly, the biological response of clearing the virus was significantly different 
for females compared to male. Females were more efficient in clearing the virus as 
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indicated by undetectable HCV RNA. (Bakr et al., 2006). The study showed that 44.6% 
of females cleared the virus compared to 33.7% of males, after adjusting for potential 
confounders. The above studies implicate that females are different than males in their 
biological response to HCV. While there is increased vulnerability due to social 
circumstances, there may be increased immunity biologically, though much more 
research is needed to confirm this. Isolating prevention factors pertaining to women 
opens up avenues for targeted public health approaches in preventing transmission of 
HCV infections among women. 
2d. Risk Factors 
a. Transmission. The mode of transmission varies greatly between industrialized 
and non-industrialized countries. In developed countries, intravenous drug abuse has been 
documented as the most common risk factor for HCV infections (Shepard, Finelli, & 
Alter, 2005). In the developing world, however, risk factors associated with increased 
risk of transmission of HCV are unsafe therapeutic injections and blood transfusion from 
unscreened blood donors (Shepard et al., 2005). A vast amount of literature shows 
evidence of transmission of hepatitis C through therapeutic procedures. The relatively 
recent discovery of HCV, much later than the advent of modern surgical and dental 
procedures enabled the virus to be a classic example of iatrogenic transmissions. As a 
result, clinicians are still seeing an increased rate of chronic hepatitis C among people 
who had received blood transfusions in the past (Prati, 2006). Egypt’s high rate of 
chronic HCV infections is attributed to iatrogenic infections caused during mass 
campaigns against schistosomiasis (Frank et al., 2000). Mass campaigns, where a large 
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number of people were given tartar emetic intravenously using glass syringes for about 
30 years up until the 1980’s has resulted in an unprecedented rate of chronic HCV 
infections, the highest in the world. However, other developing nations such as India 
have also attributed chronic HCV to unsafe injection practices used to treat Kala-azar 
(Singh, Dwivedi, Sood, & Wali, 2000). Therefore, unsurprisingly, HCV is the most 
common cause of post-transfusion hepatitis. 
b. Female Genital Mutilation [FGM]. The WHO has defined FGM as “all 
procedures involving partial or total removal of the external female genitalia or other 
injury to the female genital organs for non-medical reasons” (WHO).The WHO 
classification of FGM is as follows: Type I – partial or total removal of the clitoris and/or 
the prepuce (clitoridectomy); Type II – partial or total removal of the clitoris and the 
labia minora , with or without excision of the labia majora (excision); Type III – 
narrowing of the vaginal orifice with creation of a covering seal by cutting and 
appositioning the labia minora and/or the labia majora, with or without excision of the 
clitoris (infibulation);  Type IV – all other harmful procedures to the female genitalia for 
non-medical purposes, for example, pricking, piercing, scraping, incising, and 
cauterization (Types of FGM).  
The surgical practice of removing a part or all of the female external genitalia has 
been practiced for hundreds of years. In Egypt, for example, this practice has been around 
for more than a thousand years (Assaad, 1980). Dr. Meinardus, a sociologist, writes that 
this practice probably originated in Egypt during the time of Pharaohs. Despite the nature 
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of the practice itself, this practice has profound moral, societal and cultural significance. 
Contrary to modern belief, many mothers prefer it for their daughters in order to build a 
dignifying identity for them(Toubia, 1994). In an effort to find an explanation for the 
FGM practice in Egypt, Meinardus suggests that it is related to the Pharaonic belief in the 
bisexuality of gods;” just like the gods, every person has feminine and masculine souls, 
the feminine part of male soul resided in the prepuce and the masculine part of the female 
soul resided in the clitoris. Hence, in order for a man or woman to be fully grown up and 
be accepted into manhood and womanhood, they had to shed their feminine and 
masculine properties, respectively” (Meinardus, 1967).  Many women endure this  
practice in order to gain respect and fulfillment in their societies and as a rite of passage 
into adulthood (Assaad, 1980). 
Given the historical nature of FGM, it is often performed by traditional midwifes 
called Dayas or barbers using crude unsterile instruments, without anesthesia and with 
insufficient knowledge of female anatomy, providing many opportunities for 
transmission of infectious diseases (Diouf & Nour, 2012). A study using Demographic 
Health Survey from Kenya in  2003, showed that women who underwent FGM had 
higher odds of being HIV positive compared to their counterparts who did not go through 
FGM (Maslovskaya, Brown, & Padmadas, 2009). However, though HCV and HIV have 
similar transmission routes, some studies have shown no statistically significant 
association between FGM and HCV (Habib et al., 2003). On the other hand, male 
circumcision was found to have increased odds of association with HCV, which may be 
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explained by the fact that males are sometimes circumcised in small groups using the 
same instruments, unlike females in whom the procedure is generally performed 
individually(Habib et al., 2003). In this study, the age adjusted OR for females who were 
circumcised by an informal health provider for having HCV was 1.3 (0.5, 3.5), however, 
this was not statistically significant (Habib et al., 2003). 
c. Age. A number of host factors affect the natural history of chronic HCV; 
among them age is one of the significant factors affecting the progression of disease 
(Seeff, 2006). In a study involving 2235 patients with HCV, the progression of fibrosis 
was closely associated with aging (Poynard, Bedossa, & Opolon, 1997). A cross-
sectional survey in a rural community of the Nile Delta region revealed that anti-HCV 
prevalence increased sharply with age; in those <20 years old, anti-HCV prevalence was 
9.3% compared to >50% prevalence in those older than 35 years (Abdel‐Aziz et al., 
2000). A multivariate regression analysis for independent risk factors of a community in 
the Nile Delta region in Egypt also showed that age was an independent risk factor for 
hepatitis C (Habib et al., 2003).  
Age is not only associated with disease progression directly, but is also related 
with knowledge of HCV, with schistosomiasis treatment campaigns and with FGM.  Age 
was significantly related to knowledge and attitudes about hepatitis C in the Egypt 2008 
DHS data (EDHS)(El-Zanaty, 2009). According to the 2008 EDHS report, women 
between the age groups of 20-39 years were more likely to have known about hepatitis C 
than women younger or older. According to Arafa and colleagues (2005), the peak of 
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anti-HCV prevalence among older adults aged 40-54 years corresponds to the aging 
cohort of children who were infected through schistosomiasis campaigns in Egypt(Arafa 
et al., 2005). FGM is a ritual usually performed between the ages of 4 to 10 years, and in 
some communities it may be performed earlier (Toubia, 1994).  
d. Education. The amount of education women have in general is related to their 
knowledge of HCV in particular. The number of women knowing about hepatitis C was 
much higher among women who had completed secondary or higher education (El-
Zanaty, 2009). According to EDHS report 2008, 93.4% of women with “secondary 
education/higher” knew at least one of the ways in which the illness could be spread 
compared to only 54.2% of women who had “no education”(El-Zanaty, 2009). In a study 
involving a village with moderately high prevalence of hepatitis C in Upper Egypt, the 
risk of hepatitis C for those above 30 years old was higher among those who never 
attended college (Medhat et al., 2002). 
e. Marital status. Some believe marriage is a surrogate marker for the sexual 
transmission of HCV; however, this view has been controversial, since several studies 
reported similar, rather than higher, prevalence of HCV among heterosexuals married 
couples and men who have sex with men (MSM) (ANNEMARIE WASLEY & Alter, 
2000). MSM are usually considered a riskier sexual group and would be expected to have 
higher prevalence if the primary mode of infection was in fact sexual (Weasley& Alter, 
2000). Whatever the reason, being married seems to be a risk factor for HCV. A 
community study of a rural village of Upper Egypt showed that the risk of seropositivity 
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significantly increased with marriage (Abdel‐Aziz et al., 2000; Habib et al., 2003). In this 
study, the odds ratio of seropositivity with marriage was 4.1 (2.4-6.9) (Abdel‐Aziz et al., 
2000; Habib et al., 2003). Another assessment of the epidemiological pattern of 
transmission in a community of the Nile Delta region of  Egypt reported  that the odds 
ratio of marriage and increased risk of infection was 2.5, (1.0-6.1) (Arafa et al., 2005).  A 
study in Taiwan also concluded that the risk of transmission increases with marriage and 
duration of marriage (Memon & Memon, 2002). The Taiwanese study found that infected 
couples were more likely to have shared toothbrushes and to have had more frequent 
sexual contacts. 
f. Cesarean section.  Physiologically, the placental barrier acts a shield to protect 
the baby from several pathogens, but this protective shield is compromised during 
miscarriage, abortion, labor, and child birth. Data from HCV positive pregnant women 
suggests that perinatal transmission of HCV occurs around the time of delivery (Mok, 
Pembrey, Tovo, & Newell, 2005). In one study of  441 mother-child pairs from the UK 
and Ireland followed through pregnancy and delivery,  the findings concluded that a 
cesarean section before membrane rupture had a decreased risk of peripartum 
transmission than vaginal delivery (Gibb et al., 2000). However, whether or not cesarean 
section is a risk factor in the transmission of HCV in Egypt remains a controversy. A 
study of risk factors in rural areas of Egypt concluded that instrumental delivery 
(cesarean sections, episiotomy, ventouse) was associated with a 3.49 (1.12-10.9) fold 
increased risk of HCV transmission (Arafa et al., 2005). Another study of risk factors in 
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the Nile Delta region concluded that mothers who had cesarean sections or abortion had a 
OR of 1.4 (1.0, 1.9) for transmission of HCV (Habib et al., 2003).  
g. Type of residence. The place of residence is an indirect measure for several 
health indices, such as, access to healthcare services, education, socio-economic 
conditions, and various cultural practices that may be associated with decreased or 
increased risk of infections (Eberhardt & Pamuk, 2004). Several factors play a role in the 
pathogenesis of HCV in relation to the residence. One such factor is the relationship 
between place of residence and prevalence of schistosomiasis.   The more rural Lower 
Egypt has always had a higher rate of schistosomiasis than Upper Egypt; whereas, the 
rates in Upper and Middle Egypt increased only as a result of conversion from basin to 
perennial irrigation which accelerated the transmission of schistosomiasis. The city 
dwellers of Upper Egypt and the areas surrounding Alexandria have lower rates of 
schistosomiasis potentially explaining why rural areas have higher prevalence of HCV 
than urban areas of Egypt(Frank et al., 2000). Currently, HCV prevalence correlates 
closely to schistosomiasis prevalence in all parts of Egypt, and many blame Iatrogenic 
transmission (Frank et al., 2000).  
h. Type of FGM provider. In Egypt, FGM has been traditionally performed by 
traditional midwives known as Daya, gypsies known as Ghagharia, and also by a barber. 
A study conducted in Egypt showed that the age adjusted risk for females circumcised by 
an informal healthcare provider such as a barber or traditional birth attendants(TBA) is 
1.6 (0.7 – 3.8) (Medhat et al., 2002). However, this significance was lost in multivariate 
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analysis. These results are consistent with another study of a community in the Nile Delta 
region in which the risk of HCV for those who underwent FGM by an informal health 
provider was 1.3 (0.5 – 3.5) (Habib et al., 2003).  Similar to these 2 studies, another study 
of pregnant women in Egypt found that there is a 1.43 (1.03 – 1.98) times increased risk 
of hepatitis C, when circumcision was done by a TBA or barber (Stoszek et al., 2006).  
The government allowed the practice to be performed by medical practitioners for a 
period of time during the mid-nineties but banned FGM after the death of a 11 year old, 
who bled to death after being circumcised by a barber (Wiens, 1996). The brief 
institutionalization of FMG led to medicalization of this practice. Thereafter, 
medicalization has been fiercely debated by some as a harm-reduction practice that 
improves safety of FGM  and thereby health of women (Shell-Duncan, 2001). Other 
studies have reported medicalization as one of the factors fueling the growth of the 
practice (Ugboma, Akani, & Babatunde, 2004). 
i. Religious and cultural beliefs. There is limited evidence of religious precepts 
to the practice of FGM, although, often ignorantly, it is cited as a reason (Assaad, 1980). 
The practice is rooted in the belief that FGM moderates sexuality in women, that it 
enhances the marriageability for girls, prevents adultery, and helps maintain virginity(El-
Gibaly et al., 2002; Toubia, 1994). Since religious precepts strongly support these moral 
values, FGM is commonly used in conjunction with religion(Slack, 1988). FGM was in 
practice before the advent of Abrahamic religions; since people had earnest beliefs about 
this cultural practice, overtime, it has become embedded in the African tradition and 
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religion (Slack, 1988). Although, the Islamic religion is often cited for strengthening the 
practice; it is to be noted that FGM is not practiced in a great majority of Muslim 
countries (Wiens, 1996). Furthermore, FGM is a practice that is embedded in many 
religious cultures in Africa (Slack, 1988).  
j. Lifetime History of Medical Procedure and Injections. Since its discovery in 
1989, many developed countries implemented screening for HCV in the early 90’s(Hibbs 
et al., 1993). However, many developing countries did not practice screening of donor 
blood for HCV until recently.  Early nineties signaled the presence of transfusion 
associated hepatitis to be very high among Egyptian blood donors(Saeed et al., 1991). In 
contrast to the United States, where volunteer blood donors had about 1-4% anti-HCV, 
unpaid blood donors of Egypt were found to have anti-HCV prevalence rates of about 11-
22% (Abdel-Wahab et al., 1994). A study comparing the prevalence of HCV among 
transfused and non-transfused children in Egypt reported the prevalence of anti-HCV to 
be 55% in the study population, and among these children 92% had history of multiple 
blood transfusions for hematologic disorders(Khalifa, Mitchell, Watts, El-Samahy, & El-
Sayed, 1993). 
Injection drug use has been established as a common mode of transmission of 
HCV, and a large proportion of respondents of EDHS had received injections(El-Zanaty, 
2009). About 8 percent reported that they received injection for schistosomiasis and 93 
percent reported that they have received injection for some other purpose. Of the 
respondents, 4 out of 10 reported that the syringe or needle used for at least one of the 
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injection that they received was reused (El-Zanaty, 2009). Despite varying purposes for 
receiving and sharing injections, the risk of transmission of HCV in a country with a 
large reservoir of chronic infection is universally high (Hagan et al., 2001; Thorpe et al., 
2002). In a study of risk factors for seropositivity, dental treatment was associated with a 
slightly increased, though statistically insignificant risk of HCV (Abdel‐Aziz et al., 
2000). However, studies from other countries have reported extensive contamination of 
dental equipment after treatment of patients with hepatitis C (Piazza et al., 1995).  
2d. Summary 
Receiving treatment for Schistosomiasis has been a well-established risk factor in 
the transmission of HCV in Egypt and played a significant role in the current 
epidemiology of chronic HCV infections. Furthermore, older age group is a significant 
risk factor for HCV; this corresponds to the cohort of the ageing population who received 
Schistosomiasis treatment between 1960 and 1980. There was a clear association between 
marital status and HCV, with the risk of HCV increasing with the duration of marriage, 
which supports the hypothesis that HCV can be sexually transmitted. The role of FGM in 
the epidemiology of HCV has not been well established, and there is a limited literature 
suggesting an association between these two variables. However, there is some evidence 
to support the transmission of HCV when it is performed by an untrained, nonmedical 
professional. Lifetime history of blood transfusions has been a well-established risk 
factor in Egypt. Although studies from other countries have shown evidence of 
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associations between HCV and dental treatment, surgeries and injection sharing, there is 
limited evidence to support this hypothesis among the Egyptian population. 
The literature review examined the risk factors associated with the transmission of 
HCV infection. Emphasis was given to studies focusing on associations between HCV 
and FGM. However, a comprehensive review of general risk factors associated with the 
transmission of HCV has been included. Aligning with the overarching goal of this 
thesis, a general analysis of health consequences related to FGM has also been included. 
The literature review was used as guidance for the variables used in the analysis. 
2e. Theoretical Basis of the Study 
The burden of HCV in human physiology and economy arises from its effect to 
produce chronic disease; hence, this study evaluates the risk factors of HCV the Life 
Course Perspective as a theoretical model for chronic disease (Ben-Shlomo & Kuh, 2002; 
Hall, Yee, & Thomas, 2002). This theory acknowledges the presence of biological, 
behavioral, and psychosocial pathways that operate across all stages of an individual’s 
lifespan to cause and modify disease. This theory postulates that there is a cumulative 
burden of risk due to psychosocial and cultural determinants that influence an 
individual’s chances of acquiring disease. Therefore, women from certain psychosocial 
backgrounds have an increased risk of acquiring HCV and suffer from chronic sequel due 
to infection.                                       
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CHAPTER III 
METHODOLOGY 
3a. Data Sources and Study Population 
The source of data for the study came from the Demographic and Health Survey 
of Egypt for 2008, otherwise known as EDHS 2008. The 2008 EDHS is the ninth in this 
series of surveys conducted in Egypt. According to EDHS 2008 report, the goal of the 
2008 EDHS is to provide estimation of key health indicators; such as fertility, use of 
contraceptives, infant and child mortality, immunization levels, maternal and child health, 
and nutrition. In order to achieve this goal, nationally representative sample of 16,527 
“ever-married” women between the ages of 15-49 were interviewed. Additionally, the 
2008 EDHS also collected information of specific health issues that were relevant to the 
population of Egypt. One in four households from the sample was chosen for the health 
issues survey; 6,578 women and 5,430 men between the ages of 15-59 were interviewed.  
The key topics covered in the health issues subsample were knowledge and awareness of 
HIV/AIDS and hepatitis C, avian influenza, history of hypertension, cardiovascular 
illness, diabetes and liver disease. The survey also covered knowledge and attitude 
related to female circumcision, healthcare costs and health insurance coverage and 
collected specimens from the subsample to be tested for HIV and Hepatitis C (Fatma El-
Zanaty, 2008). 
DHS is a survey funded by USAID in less developed countries. DHS uses a 
standardized model of questionnaire across all countries that are included. Each question 
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has a particular code to maintain standardization across all countries. Surveys are 
typically conducted once every four years, and a report of key population indicators is 
published after each survey. Results of the research survey are then disseminated through 
seminars, web-based tools and other technologies and can then be further used for 
program design and evaluation. DHS caters these tools to a wide range of audiences 
including researchers. For the purpose of this study, the individual, household and 
biomarker data files from EDHS 2008 were used. All women who were interviewed for 
the health issues subsample and underwent lab testing for Hepatitis C were included in 
the analysis. 
Unlike the other two data files used for the study, the biomarker data file did not 
have a “CASEID” number. Hence, an identification number was created by 
concatenating the cluster number, household number and line number. The files were 
then merged using the key variables. 
3b. Study measures 
a. Dependent variable. HCV status was used as the main dependent variable 
throughout the analysis. HCV status was determined based on the results of the 
biomarker data file; women who tested positive for the HCV antigen were further tested 
for the presence of HCV RNA. Women who had a positive test result in either one of 
these tests were coded as being positive for HCV. This variable was computed from the 
variable named “OB03A” and “OB03B” from the biomarker data file and was originally 
labeled as Blood test result: Antigen for HCV, and Blood test result: HCV RNA, 
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respectively. HCV status was used as the main dependent variable throughout the 
analysis. All women between the ages of 15-59 who underwent Hepatitis C testing were 
included in the analysis, unless their test results showed to be “indeterminate”, making it 
unclear whether such women were positive or negative for HCV infection. The 
prevalence of Hepatitis C among women was determined through the study. 
b. Independent variables. The variables that were included in the study were 
obtained from the individual file. These measures were categorized as social-
demographic variables, behavioral variables relating to FGM, and clinical/iatrogenic 
variables that have potential associations for HCV infection. Social demographic 
variables included age, education, marital status, and type of residence; behavioral 
variables included whether or not the woman had FGM, and questions relating to 
knowledge and beliefs associated with FGM; clinical variables included history of blood 
transfusion, surgery,  history of sharing syringes or injections, history of receiving 
injections for schistosomiasis.  
 Social - Demographic Measures 
   Age. Age was obtained from the variable labeled age of respondent 
calculated. This measure had been calculated using the date of birth of the subjects who 
were surveyed in EDHS 2008. Age was a measure in whole number; this measure was 
then recoded into a categorical variable of five categories as follows; age 15-19, age 20-
29, age 30-39, age 40-49, and age 50-59. 
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Education. Education was categorized into the following groups; no education, 
some primary, primary complete/some secondary and secondary complete/higher.  
Marital status. Marital status was categorized as follows: married, widowed, 
divorced, separated, signed contract, and never married. All those who were married, 
widowed, divorced, or separated were re-coded as “ever-married” and those who had 
signed contract for marriage and never married were re-coded as “never married”. 
Residence. Residence was categorized as urban or rural. 
Measures Relating to Attitude and Behavior 
History of FGM. The survey questionnaire stated “have you yourself been 
circumcised”? The responses were either yes or no and were coded 1 and 2, respectively. 
Those who answered “no” were used as a reference value in analysis. Those who 
answered don’t know were coded as a discrete missing value.  
FGM performer. Information about the person who performed the FGM was 
obtained from question I204 of the individual file. The responses were coded as follows: 
1 for doctor, 2 for a nurse/health practitioner, 3 for daya, 4 for barber, and 5 for ghagaria. 
Those who answered “don’t know” were coded as a discrete missing value. 
Religious beliefs associated with FGM. This measure was obtained from 
question #I209 of the individual file. The responses were either “yes”, “no”, or “don’t 
know”; and were coded 1, 2 and 8, respectively. Those coded as 8 were recoded as a 
discrete missing value. 
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Belief that FGM can continue. The original code for this question was # I210 
from the individual file of EDHS 2008. An affirmative response was coded as 1 and a 
negative response was coded as 2. All the women who answered “don’t know” were 
coded as a discrete missing value. 
Measures associated with potential clinical/iatrogenic risk factors for HCV 
History of Blood transfusion. The question was originally labeled have you ever 
had a blood transfusion. A positive response was coded as 1 and a negative response was 
coded as 2. [# I501B] This response and coding was the same for all clinical measures 
stated below. 
History of Surgery. A history of any surgery in the past was stated in the 
questionnaire as, “Ever had any surgery in the past”? [# I501A]. 
History of sharing needles or syringes. EDHS questionnaire # I504 was used to 
identify this variable; the questionnaire stated, “Was the same needle or syringe used by 
somebody”? 
History of injection for schistosomiasis. This question was stated as follows: 
“ever received any injection for schistosomiasis”? [# I502A]. 
3c. Statistical Analysis 
The statistical package for Social Sciences [SPSS] version 21 was used to 
truncate, organize and analyze the data from EDHS 2008 to make it suitable for the 
study. Frequency tables to determine the distribution of HCV status across these variables 
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were cross tabulated with same. The estimation of HCV infection between different 
categories of study measures were compared using the Pearson Chi-square test, and 
univariate and multivariate logistic regression analyses were performed to estimate the 
factors associated with HCV positivity. HCV status was used as the dependent variable in 
all models [Coded as 1 for positive and 0 for a negative result]. The following 
independent variables were categorized: age, education, marital status, residence, history 
of FGM, FGM performer, religious belief for FGM, belief that FGM can continue, 
history of blood transfusion, history of surgery, history of sharing needles or syringe, 
history of injection for schistosomiasis.  A P-value of <0.05 and a confidence interval of 
95% were used to determine statistical significance throughout the analysis.  
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Chapter IV 
Results 
4a. Sample Demographics 
The total number of EDHS respondents who met the study eligibility criteria was 
6569 out of which 711 were found to be HCV positive. The demographic profile of 
participants with respect to independent variables is presented below in table 1. About 
32% of respondents were between the ages of 20-29, making this the largest category 
among all age groups. Around 40% of the respondents had completed secondary or 
higher education, 74% were married and 58% resided in a rural area. An overwhelming 
90.9% of respondents had a history of FGM; 52% believed in religious precepts for 
FGM; and 56% believe that the practice can continue. Only 4.2% of respondents had a 
history of blood transfusion, while 45.9% had a history of surgery. Similarly only3.8% 
had a history of sharing needles or syringes, and only 5.1% had received injection for 
schistosomiasis. 
 
 
 
 
 
27 
 
27 
 
 
 
            Table 1: Sample Size and percentage of women included in the study from 
EDHS 2008 
Variables N % 
Age   
15-19 1106 16.8 
20-29 2110 32.1 
30-39 1447 22.0 
40-49 1161 17.6 
50-59 754 11.5 
Education   
No education 2048 31.1 
Some primary 536 8.1 
Primary complete/some secondary 1378 20.9 
Secondary complete/higher 2616 39.8 
Marital Status   
Ever married 4914 74.8 
Never married 1655 25.2 
Residence   
Urban 2745 41.8 
Rural 3824 58.2 
History of FGM   
Yes 5962 90.9 
No 600 9.1 
Religious belief for FGM   
Yes 3434 52.3 
No 1895 28.8 
Belief that FGM can continue   
Yes 3683 56.1 
No 2156 32.8 
History of blood transfusion   
Yes 276 4.2 
No 6276 95.5 
History of surgery 
 
  
Yes 3012 45.9 
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No 3547 54 
History of sharing needle or syringe   
Yes 252 3.8 
No 5679 86.5 
History of injection for Schistosomiasis   
Yes 332 5.1 
No 6136 93.4 
 
4b. Distribution of variables across HCV status 
The distribution characteristics of eligible participants across HCV status is 
shown in Table 2.  There were statistically significant differences between subjects who 
were HCV positive and those who were HCV negative with respect to age, education, 
marital status and residence(P <0.05). As shown, the age group of 40-49 represented the 
cohort with the largest HCV positive people compared to other age categories that were 
investigated. The highest proportion of HCV positive people were in the no education 
group (54.6%), followed by the secondary complete/higher category (22.2%), primary 
complete/secondary category (12.1%) and some primary (11.1%). The ever married 
group and rural residents had higher proportions of HCV positives than their respective 
counterparts. The groups with affirmative responses to history of FGM, religious precept 
to FGM, belief that FGM can continue, blood transfusion, surgery, sharing needles and 
injection for schistosomiasis all had higher proportions of HCV positives than their 
respective counterparts. There was a statistically significant difference between the HCV 
positive and negative groups across all variables. 
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Table 2: Distribution characteristics of participants by HCV status; the P-value 
signifies difference between HCV positive and negative groups 
Variable HCV positive 
% 
HCV 
negative% 
P - 
value 
Age category    <0.05 
15-19 3.9 18.4  
20-29 14.2 34.3  
30-39 21.1 22.1  
40-49 32.5 15.8  
50-59 28.3 9.4  
Education    <0.05 
No education 54.6 28.3  
Some primary 11.1 7.8  
Primary complete/some secondary 12.1 22.0  
Secondary complete/higher 22.2 41.9  
Marital Status    <0.05 
Ever married 91.8 72.7  
Never married 8.2 27.3  
Residence   <0.05 
Urban 26.0 43.7  
Rural 74.0 56.3  
History of FGM   <0.05 
Yes 97.7 90.0  
No 2.3 10.0  
Religious belief for FGM   <0.05 
Yes 77.8 62.8  
No 22.2 37.2  
Belief that FGM can continue   <0.05 
Yes 79.4 61.1  
No 20.6 38.9  
History of blood transfusion   <0.05 
Yes 6.9 3.9  
No 93.1 96.1  
History of surgery   <0.05 
Yes 52.5 45.1  
No 
 
 
47.5 54.9  
History of sharing needles or   <0.05 
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syringe 
Yes 6.0 4.0  
No 94.0 96.0  
History of injection for 
schistosomiasis 
  <0.05 
Yes 10.9 4.4  
No 89.1 95.6  
 
4c. Association between FGM and other independent variables with HCV status 
Results of the univariate analysis of the association between independent variables and 
HCV are shown in Table 3. In the univariate model, subjects who have had FGM had 
4.82 (2.91 – 7.96) increased odds of HCV compared to those who did not have FGM. A 
linear increase in odds of HCV with increasing age was apparent and ranged from 1.94 to 
14.10 in subjects in the 20-29 to 50-59 age categories, respectively.  The results of 
univariate analysis also showed that lack of education and primary education were 
associated with increased odds of HCV compared to subjects who have completed 
secondary education, OR of  3.64 (3.00, 4.43) and 2.69 (2.02, 3.59), respectively. Ever 
been married and rural residency was each associated with increased odds of HCV, OR 
of 4.22 (3.21-5.55) and 2.21 (1.85-2.63), respectively. A religious belief for FGM and a 
positive response for FGM can continue are also associated with 2.08 (1.69 – 2.55) and 
2.45 (2.01 – 3.00), respectively, increased odds of HCV infection. Iatrogenic factors such 
as a positive history of blood transfusion, surgery, sharing needles, and a history of 
schistosomiasis is associated with 1.84 (1.34 – 2.53), 1.35 (1.15 – 1.57), 1.51 (1.07 – 
2.15), and 2.63 (2.01 – 3.45), respectively, increased odds of HCV infection. 
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Table 3: Association of FGM and HCV status; the OR (95% CI) represents the odds 
ratio after univariate analysis 
Variable OR (95% CI) P-value 
History of FGM   
Yes 4.82 (2.91 – 7.96) <0.05 
No Reference  
Age category    
15-19 Reference  
20-29 1.94 (1.27-2.96) <0.05 
30-39 4.46 (2.95 -6.72) <0.05 
40-49 9.58 (6.41-14.32) <0.05 
50-59 14.10 (9.37-21.21) <0.05 
Education   
No education 3.64 (3.00 - 4.43) <0.05 
Some primary 2.69 (2.02 - 3.59) <0.05 
Primary complete/some 
secondary 
1.04 (0.79 - 1.36) >0.05 
Secondary complete/higher  Reference  
Marital Status    
Ever married 4.22 (3.21 – 5.55) <0.05 
Never married Reference  
Residence   
Rural 2.21 (1.85 - 2.63) <0.05 
Urban Reference  
Religious belief for FGM   
Yes 2.08 (1.69 – 2.55) <0.05 
No  Reference  
Belief that FGM can continue   
Yes 2.45 (2.01 – 3.00) <0.05 
No Reference  
History of blood transfusion   
Yes 1.84 (1.34 - 2.53) <0.05 
No Reference  
History of surgery   
Yes 1.35 (1.15 – 1.57) <0.05 
No 
 
 
Reference  
History of sharing needles or   
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syringe 
Yes 1.51 (1.07-2.15) <0.05 
No Reference  
History of injection for 
schistosomiasis 
  
Yes 2.63 (2.01 - 3.45) <0.05 
No Reference  
 
4d. Association of FGM and HCV status in multivariate analysis 
 Based on the univariate analysis and literature review, age and schistosomiasis 
injection were controlled for in the multivariate analysis shown in table 4 below. 
Adjusting for age and schistosmiasis injection, the odds of association between FGM and 
HCV infection decreased from 4.82 to 2.98 (1.76 – 5.05). Other independent variables 
that had a statistically significant association with HCV status were education, residence, 
and beliefs. Adjusting for age and schistosomiasis injections, participants who lacked 
education had increased odds of association with HCV infection compared to those who 
completed secondary education with an OR of 2.08(1.68 – 2.57). Living in a rural 
residence also had a statistically significant association with HCV infection with OR of 
2.60 (2.16 – 3.14), compared to urban residents. After adjusting for age and 
schistosomiasis injection, religious beliefs and an affirmative response to FGM can 
continue each had increased odds of association with HCV infection with OR of 1.53 
(1.23 – 1.89), and 1.69 (1.37 – 2.10), respectively. 
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Table 4: Association of FGM and HCV infection after adjustment for age and 
schistosomiasis injection 
Variable OR (95% CI) P-value 
History of FGM   
Yes 2.98 (1.76 – 5.05) <0.05 
No Reference  
Education   
No education 2.08 (1.68 – 2.57) <0.05 
Some primary 1.57 (1.15 – 2.14) <0.05 
Primary complete/some 
secondary 
1.22 (0.91 - 1.62) >0.05 
Secondary complete/higher  Reference  
Marital Status    
Ever married 1.39 (0.98 – 1.98) >0.05 
Never married Reference  
Residence   
Rural 2.60 (2.16 – 3.14) <0.05 
Urban Reference  
Religious belief for FGM   
Yes 1.53 (1.23 – 1.89) <0.05 
No  Reference  
Belief that FGM can continue   
Yes 1.69 (1.37 – 2.10) <0.05 
No Reference  
History of blood transfusion   
Yes 1.35 (0.96 – 1.91) >0.05 
No Reference  
History of surgery   
Yes 1.05 (0.89 – 1.25) >0.05 
No Reference  
History of sharing needles or 
syringe 
  
Yes 1.33 (0.91 - 1.95) >0.05 
No Reference  
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Table 5: Association between various categories FGM performer and HCV infection 
in the univariate model 
 
Variable  OR (95% CI) P - value 
FGM performer   
Doctor Reference  
Nurse/other health provider 2.53 (1.65 – 3.89) <0.05 
Daya* 3.68 (2.76 – 4.90) <0.05 
Barber 3.30 (1.85 – 5.88) <0.05 
Ghagaria* 4.28 (2.31 – 7.91) <0.05 
*Daya – traditional midwife; * Ghagaria – Gypsy 
 
4e. Association of FGM performer and HCV infection 
Table 5 shows comparison of odds of HCV across performer of FGM using Doctors as 
reference (Figure1). As shown, subject who received FGM from non-physicians had a 
much increased odds of HCV. Compared to doctors, subjects who received FGM from 
nurses, Daya, Barbers and Ghagaria had 2.53(1.65 – 3.89), 3.68(2.76 – 4.90), 3.30(1.85 – 
5.88) and 4.28(2.31 – 7.91) increased odds of HCV, respectively.  
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Figure 1: Association of various FGM performer and HCV infection 
 
 
*Daya – traditional midwife; * Ghagaria - Gypsy 
 
Table 6 shows the association for FGM performer and HCV infection in the multivariate 
analysis. As shown, after adjusting for age and injection for schistosomiasis, subjects 
who received FGM from nurses and daya had increased odds of 1.75 (1.12 – 2.74), and 
1.66 (1.22 – 2.27), respectively.  
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Table 6: Association of FGM performer and HCV infection after adjusting for age 
and injection for schistosomiasis 
 
Variable  OR (95% CI) P - value 
FGM performer   
Doctor Reference  
Nurse/other health provider 1.75 (1.12 – 2.74) <0.05 
Daya* 1.66 (1.22 – 2.27) <0.05 
Barber 1.51 (0.82 – 2.76) >0.05 
Ghagaria* 1.33 (0.69 – 2.58) >0.05 
*Daya – traditional midwife; * Ghagaria - Gypsy 
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Chapter V 
Discussion and Conclusion 
5a. Discussion 
  Studying factors associated with HCV infection play an important role in 
facilitating programs that target prevention. HCV in Egypt has been quoted as a 
socioeconomic disease that is attributable to social practices that can be prevented 
through  infection control in the healthcare industry (Yahia, 2011). Further, treatment of 
chronic HCV in Egypt has a cost higher than the median income rate of Egypt(Yahia, 
2011).  Hence; there is an urgent need for prevention to reduce the societal, economic and 
health burden of the disease. There are a few studies that have studied associations of 
female circumcision and Hepatitis C; however, not many have utilized a nationally 
representative population of Egypt. This is particularly important since prevention of 
hepatitis will not only reduce the burden of disease in women, but may also have an 
impact in reducing the risk of transmission in their sexual partners and offspring. There is 
also a limitation in the literature, associating FGM with HCV; therefore, this study is 
significant in implicating this traditional practice, which may play a role in decreasing the 
incidence of HCV, particularly in women. 
Association between HCV infection and FGM  
The study objective was to find the association between FGM and chronic HCV 
in Egypt using EDHS 2008. The study utilized self-reported female circumcision and 
laboratory measures to detect the prevalence of HCV. The main question of the study was 
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whether prevalence of HCV was different in women who had FGM compared to women 
who did not have FGM. The unadjusted OR of HCV for women who had FGM was 4.82 
(2.91 – 7.96); and after adjustment for age and schistosomiasis injection, the OR was 2.98 
(1.76 – 5.05). The OR obtained in this study is higher than the estimates obtained from 
other studies. In a study by Habib et al, the age adjusted OR for females who were 
circumcised by an informal health provider was 1.3 (0.5, 3.5), however, this was not 
statistically significant(Habib et al., 2003). Although Schistosomiasis has been a well-
established factor for the current prevalence rates of HCV, our study consistently also 
showed an association of FGM with HCV infections (Frank et al., 2000). This finding is 
in contrast to the study by Medhat et al, which concluded that circumcision per se was 
not associated with HCV(Medhat et al., 2002).  The question we attempted to answer is 
whether there was an association between FGM and HCV even after controlling for all 
known confounders from the literature and univariate analysis. This is significant because 
it shows that there is a direct relationship between FGM and HCV infections. However, it 
should be noted that we did not look at the effect of transmission of HCV through other 
possible routes such as C-sections and episiotomy during childbirth. 
Relationship between HCV infection and the type of provider who performs FGM  
The variable “FGM performer” was used in univariate logistic regression analysis 
with the objective of answering whether there was a difference in association between 
HCV status, when it was performed by traditional midwives called daya, gypsies who are 
called ghagaria, and barbers.  Among all categories of people performing the 
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circumcision, FGM performed by a nurse/other health provider had the lowest OR of 
2.53 (1.65 – 3.89). Among all unskilled professionals, FGM performed by ghagaria had 
the highest OR for HCV of 4.28 (2.31 – 7.91).  Circumcision performed by barber and 
daya had a POR of 3.30 (1.85 – 5.88), and 3.68 (2.76 – 4.90), respectively. These ORs 
are all higher than  ones reported by Medhat et al. (2002) which found that the age 
adjusted OR for HCV and female circumcision when performed by informal providers 
was 0.4 (0.2 – 1.2)  and by Stoszek et al (2006), were it was concluded that being 
circumcised by a barber or traditional birth attendant was associated with HCV with an 
OR of 1.53 (0.94 – 2.57). The OR reported by Habib et al. (2003) for circumcisions by an 
informal health provide,OR of 1.7 (1.00 - 3.00), was the closest to the current study 
results found in the literature, but the former finding was only applicable to boys over 
20.Although many of the findings from the literature have not shown statistical 
significance, the findings from this study suggest increased odds for HCV when the 
circumcision is performed by a daya, ghagaria, or barber. Adjusting for age and 
schistosomiasis injection, the association of HCV when FGM performer was a nurse or a 
daya remained statistically significant. The adjusted OR was 1.75 (1.12 – 2.74) and 1.66 
(1.22 – 2.27), respectively. In light of these results, it is arguable whether or not 
“medicalization” or legally allowing female circumcision to be performed by medical 
professionals may decrease the incidence of disease (Shell-Duncan, 2001). The secondary 
goal of this study was to assess the relationship between FGM and HCV and we found 
that there is in fact a relationship between the provider and HCV. Medical professionals 
have the lowest odds of association with HCV. An additional benefit of using medical 
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provider is the opportunity of educating women of the risks associated with the practice 
of FGM. This is significant because of ongoing argument of medicalization; however, 
despite reduced risk of HCV when FGM is performed by medical profession, the risk of 
contracting HCV from FGM is still present. FGM is a risk, and if a ban was possible 
might be the best course of action, and in its absence, allowing the medical profession to 
conduct FGM reduces the transmission of HCV infections. The potential side effect of 
medicalization is institutionalization of the practice of FGM; however, there is an 
opportunity for providing counseling for women through the medical profession in 
addition to reduction of HCV transmission. 
Associations between social-demographic factors and HCV infection 
Age consistently emerged as a variable that was strongly associated with HCV in 
women. There was a linear increase in odds of association with HCV across the age 
categories 30-39, 40-49, 50-59 with OR of 4.46 (2.95 – 6.72), 9.58 (6.41 -14.32) and 
14.10 (9.37 -21.21), respectively. This is consistent with the finding that those who may 
have received schistosomiasis injections as children currently belong to this aging cohort 
of adults(Arafa et al., 2005). Even after adjustment for age and schistosomiasis injection, 
education was a variable of statistical significance. Subjects who had no education and 
those with some primary education had increased odds of association for HCV infection 
compared to women who had completed secondary education or higher, with an OR of 
2.08 (1.68 – 2.57) and 1.57 (1.15 – 2.14), respectively. Although the association between 
education and HCV has not been particularly studied, there have been studies associating 
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health, in general, with education(Lleras-Muney, 2005; Lynch, 2003), which suggests 
that education plays an important role in accessing healthcare, cost of living, socio-
economic status and so forth. Our study results could be explained by this theory that 
education may play a role in any disease outcome. The association between marital status 
and HCV infection did not show statistical significance in either the univariate or 
multivariate models in our study. This is inconsistent with the finding by previous studies 
which showed a significant association between marriage and HCV (Abdel‐Aziz et al., 
2000; Arafa et al., 2005; Habib et al., 2003). The finding that rural residence had 
increased odds of association with HCV is consistent with the study by Frank et al; in our 
study, subjects residing in rural areas had an OR of 2.60 (2.16 – 3.14) after adjusting for 
age and schistosmiasis injection(Frank et al., 2000). 
Relationship between HCV infection and knowledge and attitudes of women 
regarding FGM 
This measure is one of the unique natures of this study due to a limitation in the 
literature with regards to people’s beliefs regarding circumcision and how this affects the 
transmission of HCV. The most common reasons for FGM were religious beliefs and to 
follow the ancestral culture (Assaad, 1980). Adjusting for age and schistosomiasis, the 
OR for the association between HCV and religious belief is 1.53 (1.23 – 1.89), and the 
OR for HCV and an affirmative response for FGM can continue is 1.69 (1.37 – 2.10).  
This result is supported by a study done by Sayed et al. (1996) which found that 92% of 
mothers who allowed their daughters to be circumcised were illiterate and additionally 
the most prevalent reason for the practice was because it followed customs and beliefs 
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(Sayed, El-Aty, & Fadel, 1996). Therefore, this finding raises concerns about whether 
abolition of the practice is feasible in the near future and whether medicalization can 
provide a solution to decrease the incidence of HCV infection (Shell-Duncan, 2001). 
Prevention programs should take into the consideration the fact that most people wish to 
continue the practice, and therefore should not focus on eradication or banning of the 
practice per se. For instance, a law banning this practice may not be effective in curtailing 
the practice but could instead lead people to obtain services from less sanitary 
knowledgeable providers such barbers and gypsies. Perhaps to facilitate the reduction of 
HCV transmission associated with FGM, religious leaders and medical professionals 
could serve as counselors to local people. Religious leaders are key stakeholders since 
many people have religious precepts for FGM. 
Analysis of clinical/iatrogenic risk factors such as a history of blood transfusion, 
surgery, injection for schistosomiasis, and injection sharing, and the relationship 
with HCV infection 
Consistent with the literature from the early nineties, the results from our study 
showed a statistically significant relationship of blood transfusion with HCV, with an OR 
of 1.84 (1.34 – 2.53) (Abdel-Wahab et al., 1994; Hibbs et al., 1993). However, after 
adjusting for age and schistosomiasis injection, this relationship between blood 
transfusion and HCV infection was no longer statistically significant. An analysis of the 
relationship between surgery and HCV infection, revealed an association between history 
of surgery and HCV, OR of 1.35 (1.15 – 1.57). Although intravenous drug use (IVDU) is 
uncommon in Egypt, sharing medical equipment and syringes are culturally acceptable 
and may have contributed to HCV (Medhat et al., 2002; Yahia, 2011). Our study results 
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revealed an increased odds of association between history of injection sharing and HCV 
infection, with an unadjusted OR of 1.51 (1.07- 2.15). Regardless of the purpose of 
receiving injections; those who had shared the syringe or needle had a higher risk for 
HCV. Among all clinical variables, having had an injection for schistosomiasis remained 
statistically significant in multivariate analysis. This finding is consistent with the vast 
amount of literature supporting the relationship(Frank et al., 2000; Strickland, 2006). 
Most notably, in addition to history of injection for schistosomiasis, having had FGM 
remained statistically significant in multivariate analysis, even after adjusting for age and 
schistosomiasis.  
5b. Limitations 
There are some limitations to the study. Although DHS uses a standardized 
questionnaire and is designed to be a robust survey across countries, there are 
opportunities for self-report bias with any secondary data. Secondly, a vast majority of 
women included in this study had FGM, which may have strengthened the magnitude of 
the relationship between FGM and HCV infections. 
5c. Recommendations 
Future studies’ analyzing the relationship between FGM and HCV among women 
is warranted. Specifically, new studies need to employ recent data from EDHS 2012. A 
more robust model would be to compare equal proportions of women who had FGM with 
those who did not have FGM. Studies can also employ subjects from other countries to 
compare similar relationships. Additionally, future studies need to consider preconceived 
notions and beliefs and employ methods to quantify the association with HCV infections. 
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Our study results reveal that many of the women would prefer for this practice to be 
continued and that it is required by religious precepts. Among study subjects, more than 
50% of women provided affirmative answers to religious precepts and FGM can 
continue. In light of these results; it is necessary to consider that women may obtain FGM 
through lay providers such as traditional midwives, barbers, and gypsies and put 
themselves at risk for HCV infection. 
5d. Strengths of the study 
 Despite limitations, this study has some notable strength. DHS employs a 
nationally representative sample, and therefore the results of the study can be applicable 
to the Egyptian women. Our study also included several variables that have not been 
analyzed by previous studies; such as beliefs regarding FGM, and its association with 
HCV infections.  
5e. Conclusion 
Prevention efforts need to be designed based on specific characteristics such as 
women with less education and rural neighborhoods. Similarly, prevention efforts need to 
be implemented with cultural sensitivity; educating religious leaders about the harmful 
effects of FGM may provide an efficient means of bringing the practice to an end.  The 
Ministry of Health Program in Egypt institutes two programs for HCV; the first program 
aims at providing treatment for those already infected with HCV(Yahia, 2011). The 
second program facilitates prevention efforts. Re-directing funds towards prevention 
programs, in addition to ongoing treatment of infected individuals is the most effective 
means of reducing the burden of HCV in Egypt. The results of this study help provide 
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useful insights to public health professionals to design and implement programs that are 
efficient in preventing HCV transmission in Egypt. 
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